TolerRx's Series C - II Round

TolerRx raised a round of funding on January 24, 2003.

TolerRx is discovering, developing, and seeking to commercialize therapies designed to treat patients by reprogramming the immune system, allowing for long-term remission of immune-related diseases - …

Articles about TolerRx's Series C - II Round: